TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 3.5nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 4.80nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Antagonist activity at rat UT receptor transfected in CHOK1 cells assessed as calcium mobilization by FLIPR methodMore data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 16nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 16nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 16nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHO cells assessed as calcium mobilization at 10000 nM by FLIPRMore data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 23nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 29nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 34nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 39nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 53nMAssay Description:Antagonist activity at rat UT receptor transfected in CHOK1 cells assessed as calcium mobilization by FLIPR methodMore data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 69nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 75nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 80nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 84nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 100nMAssay Description:Antagonist activity at rat UT receptor transfected in CHOK1 cells assessed as calcium mobilization by FLIPR methodMore data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 130nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 180nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 210nMAssay Description:Antagonist activity at rat UT receptor transfected in CHOK1 cells assessed as calcium mobilization by FLIPR methodMore data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 300nMAssay Description:Antagonist activity at rat urotensin 2 receptor expressed in CHOK1 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobiliza...More data for this Ligand-Target Pair
TargetUrotensin-2 receptor(RAT)
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 330nMAssay Description:Antagonist activity at rat UT receptor transfected in CHOK1 cells assessed as calcium mobilization by FLIPR methodMore data for this Ligand-Target Pair